Michael Okonkwo

Michael Okonkwo

IPO & Growth Analyst

Michael Okonkwo is an IPO and growth equity analyst at StockTi. He holds an MBA from Wharton and previously worked in venture capital, giving him a unique perspective on pre-IPO valuations and public market debuts. Michael covers new listings, SPAC transactions, and high-growth companies across all sectors. His analysis focuses on identifying inflection points in emerging companies transitioning from private to public markets.

IPO, Growth Stocks 180 articles

Articles by Michael Okonkwo

SpaceX IPO Debuts at $1.77 Trillion, High Valuation and Low Free Float Key Concerns
IPO

SpaceX IPO Debuts at $1.77 Trillion, High Valuation and Low Free Float Key Concerns

SpaceX's IPO priced at $135 per share, giving it a $1.77 trillion valuation. The stock starts trading with only 7% of shares freely tradable, and analysts have mixed views on its fair value.

U.S. Futures Edge Higher as SpaceX Debut Looms, Oil Prices Plunge
IPO

U.S. Futures Edge Higher as SpaceX Debut Looms, Oil Prices Plunge

U.S. stock futures edged higher Friday as investors brace for SpaceX's record $75 billion IPO and a steep decline in oil prices, while producer inflation data raises rate hike concerns.

SPY QQQ DIA AMD NVDA TSLA GOOGL MU ADBE SPCE
SpaceX's Record-Breaking $75B IPO Debuts at $135 Per Share
IPO

SpaceX's Record-Breaking $75B IPO Debuts at $135 Per Share

SpaceX completed the largest IPO in history, raising $75 billion by selling 555.6 million shares at $135 each. Trading begins Friday on Nasdaq.

QQQ SPY
Elon Musk on Track to Become First Trillionaire After SpaceX IPO
IPO

Elon Musk on Track to Become First Trillionaire After SpaceX IPO

Elon Musk is poised to become the world's first trillionaire after SpaceX's IPO, with a valuation of $1.77 trillion, pushing his fortune over the trillion-dollar mark.

SPY QQQ TSLA SE SNDK ORCL GLD SLV USO UNG XLK XLF XLE
Rocket Lab Stock Rides SpaceX IPO Wave, Analyst Stays Neutral
IPO

Rocket Lab Stock Rides SpaceX IPO Wave, Analyst Stays Neutral

Rocket Lab shares jumped 9.26% to $114.78 as SpaceX IPO speculation reignites interest in space stocks, even as KGI Securities initiates coverage with a Neutral rating and $105 target.

RKLB
Voyager Technologies Stock Surges on Bullish Analyst Initiation and SpaceX IPO Buzz
IPO

Voyager Technologies Stock Surges on Bullish Analyst Initiation and SpaceX IPO Buzz

Voyager Technologies shares jumped 17% after BTIG initiated coverage with a Buy rating and $55 price target, with the rally amplified by growing investor enthusiasm for space and defense stocks ahead of SpaceX's IPO.

VOYG SPY QQQ DIA
EchoStar Shares Soar on SpaceX IPO Anticipation
IPO

EchoStar Shares Soar on SpaceX IPO Anticipation

EchoStar shares jumped 9.1% to $125.67 as SpaceX's $75 billion IPO nears, with the company seen as a key proxy for SpaceX exposure due to spectrum deals.

SATS NDAQ TSLA GOOGL META T BLK
Momentus Shares Surge 42% on Space Sector Momentum and SpaceX IPO Buzz
IPO

Momentus Shares Surge 42% on Space Sector Momentum and SpaceX IPO Buzz

Momentus Inc. shares jumped over 42% to $16.13 on heavy volume, riding a space sector rally tied to SpaceX IPO expectations. The company reports $76M cash, zero debt, and progress on its Vigoride 7 mission.

MNTS
Robinhood Surges as IPO Underwriting Nod Opens New Revenue Streams
IPO

Robinhood Surges as IPO Underwriting Nod Opens New Revenue Streams

Robinhood shares jumped 3% to $86.36 as the broker gains approval to underwrite IPOs, moving closer to Wall Street's core. The move comes as SpaceX's IPO draws massive retail demand and CFTC weighs event contract regulations.

HOOD
SpaceX IPO Draws Record $250 Billion in Orders, Priced at $135
IPO

SpaceX IPO Draws Record $250 Billion in Orders, Priced at $135

SpaceX's $75 billion IPO is 3.5x oversubscribed with $250 billion in orders, priced at $135 a share for a $1.75 trillion valuation. Starlink growth offsets a $4.94 billion net loss and 94x price-to-sales ratio.

TSLA NVDA GOOGL AMZN
Parabilis Medicines Rockets 58% in Nasdaq Debut After Record $670M IPO
IPO

Parabilis Medicines Rockets 58% in Nasdaq Debut After Record $670M IPO

Parabilis Medicines (PBLS) closed at $31.60 on its first trading day, a 58% jump from the $20 IPO price, after raising $670 million.

REGN
ERock Stock Falls Below IPO Price on NYSE Debut Amid AI Power Contract Doubts
IPO

ERock Stock Falls Below IPO Price on NYSE Debut Amid AI Power Contract Doubts

ERock (EROC) fell 12.37% in its NYSE debut, closing at $18.84 as investors worried about its $1.28B AI data-center backlog.

META